Skip to content

Impact of Rikkunshito administration on gastrointestinal function after major hepatectomy

Impact of Rikkunshito administration on gastrointestinal function after major hepatectomy - Impact of Rikkunshito administration on gastrointestinal function after major hepatectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018436
Enrollment
40
Registered
2015-07-27
Start date
2012-08-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatectomy patients

Interventions

Rikkunshito 2.5g, 3 times per day 6 months administration control

Sponsors

Nippon Medical School, Tamanagayama hospital, Department of surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Major hepatectomy patients 2.Performance Status 0 or 2 3.Patients capable of per os 4.over 20years old and under 85years old

Exclusion criteria

Exclusion criteria: 1.Patients of emergency operation 2.Patients who underwent gastrectomy 3.Patients who underwent colectomy simultaneously

Design outcomes

Primary

MeasureTime frame
Improvement of gastrointestinal disorder

Countries

Japan

Contacts

Public ContactAtsushi Hirakata

Nippon Medical School, Tamanagayama hospital Department of surgery

hirakata@nms.ac.jp042-371-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026